These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 12802842)

  • 1. Three new drugs for hyperlipidemia.
    Conn Med; 2003 May; 67(5):279-81. PubMed ID: 12802842
    [No Abstract]   [Full Text] [Related]  

  • 2. Three new drugs for hyperlipidemia.
    Med Lett Drugs Ther; 2003 Mar; 45(1151):17-9. PubMed ID: 12612501
    [No Abstract]   [Full Text] [Related]  

  • 3. FPIN's clinical inquiries. Best alternatives to statins for treating hyperlipidemia.
    Bouknight P; Mackler L; Heffington M
    Am Fam Physician; 2007 Oct; 76(7):1027-9. PubMed ID: 17956075
    [No Abstract]   [Full Text] [Related]  

  • 4. [Advances in pharmacotherapy of arteriosclerosis].
    Balewska K; Witanowska A
    Pol Tyg Lek; 1990 Feb 5-12; 45(6-7):103-7. PubMed ID: 2216947
    [No Abstract]   [Full Text] [Related]  

  • 5. Safety and compliance with once-daily niacin extended-release/lovastatin as initial therapy in the Impact of Medical Subspecialty on Patient Compliance to Treatment (IMPACT) study.
    Rubenfire M;
    Am J Cardiol; 2004 Aug; 94(3):306-11. PubMed ID: 15276093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lovastatin and extended-release niacin combination product: the first drug combination for the management of hyperlipidemia.
    Gupta EK; Ito MK
    Heart Dis; 2002; 4(2):124-37. PubMed ID: 11975844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New perspectives on the use of niacin in the treatment of lipid disorders.
    McKenney J
    Arch Intern Med; 2004 Apr; 164(7):697-705. PubMed ID: 15078639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Niacin extended-release/lovastatin: combination therapy for lipid disorders.
    Moon YS; Kashyap ML
    Expert Opin Pharmacother; 2002 Dec; 3(12):1763-71. PubMed ID: 12472373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lowering low-density lipoprotein cholesterol: statins, ezetimibe, bile acid sequestrants, and combinations: comparative efficacy and safety.
    Hou R; Goldberg AC
    Endocrinol Metab Clin North Am; 2009 Mar; 38(1):79-97. PubMed ID: 19217513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid-altering efficacy and safety of ezetimibe/simvastatin coadministered with extended-release niacin in patients with type IIa or type IIb hyperlipidemia.
    Guyton JR; Brown BG; Fazio S; Polis A; Tomassini JE; Tershakovec AM
    J Am Coll Cardiol; 2008 Apr; 51(16):1564-72. PubMed ID: 18420099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adipokines and treatment with niacin.
    Westphal S; Borucki K; Taneva E; Makarova R; Luley C
    Metabolism; 2006 Oct; 55(10):1283-5. PubMed ID: 16979396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Drugs in hyperlipidemia].
    Stuyt PM
    Ned Tijdschr Geneeskd; 1987 Sep; 131(36):1554-8. PubMed ID: 3670435
    [No Abstract]   [Full Text] [Related]  

  • 13. [Influence of combined, hypolipemic therapy on lipids and non-lipid atherosclerosis risk factors].
    Broncel M; Balcerak M; Chojnowska-Jezierska J
    Pol Merkur Lekarski; 2007 Jan; 22(127):62-5. PubMed ID: 17477094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Niaspan: new hope for heart patients.
    Creavin T
    Drug Discov Today; 2005 Jan; 10(1):4-5. PubMed ID: 15676289
    [No Abstract]   [Full Text] [Related]  

  • 15. [Drug treatment of hyperlipidemia].
    Noseda G
    Ther Umsch; 1987 Aug; 44(8):578-83. PubMed ID: 3672411
    [No Abstract]   [Full Text] [Related]  

  • 16. Side effects and complications. Extended-release high-dose niacin helps lower lipid levels.
    TreatmentUpdate; 2005 Dec; 17(7):7-8. PubMed ID: 17225322
    [No Abstract]   [Full Text] [Related]  

  • 17. Statins and fibrates in the management of diabetic dyslipidemia.
    Durrington P
    Diabet Med; 1997 Jul; 14(7):513-6. PubMed ID: 9223386
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy of extended-release niacin with lovastatin for hypercholesterolemia: assessing all reasonable doses with innovative surface graph analysis.
    Insull W; McGovern ME; Schrott H; Thompson P; Crouse JR; Zieve F; Corbelli J
    Arch Intern Med; 2004 May; 164(10):1121-7. PubMed ID: 15159270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ezetimibe/Simvastatin (vytorin) for hypercholesterolemia.
    Goldman-Levine JD; Bohlman LG
    Am Fam Physician; 2005 Nov; 72(10):2081-2. PubMed ID: 16342840
    [No Abstract]   [Full Text] [Related]  

  • 20. [How sure is the combined lipid lowering?].
    Schäfer J
    MMW Fortschr Med; 2005 Jan; 147(1-2):56. PubMed ID: 15704576
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.